S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Why Lucid Spiked Nearly 100% In One Day
The Next Big Crisis Is Here (Ad)
Ride These Railroad Stocks for Growth and Income
Is Buying an Aged Corporation a Good Idea?
The Next Big Crisis Is Here (Ad)
MarketBeat Week in Review – 1/23- 1/27
Visa, L3Harris rise; Intel, Eastman Chemical fall
Is This The End of Capitalism? (Ad)
How major US stock indexes fared Friday 1/27/2023
Closing prices for crude oil, gold and other commodities

Amdocs Limited (NASDAQ:DOX) Shares Sold by Glenmede Trust Co. NA

Glenmede Trust Co. NA decreased its position in Amdocs Limited (NASDAQ:DOX - Get Rating) by 4.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 368,395 shares of the technology company's stock after selling 16,378 shares during the quarter. Glenmede Trust Co. NA owned 0.28% of Amdocs worth $29,268,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of DOX. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Amdocs during the first quarter worth approximately $104,410,000. Parnassus Investments LLC bought a new stake in Amdocs in the second quarter valued at $70,330,000. Harel Insurance Investments & Financial Services Ltd. bought a new stake in Amdocs in the second quarter valued at $39,607,000. Bain Capital Public Equity Management II LLC lifted its stake in Amdocs by 67.3% in the second quarter. Bain Capital Public Equity Management II LLC now owns 1,099,903 shares of the technology company's stock valued at $91,633,000 after buying an additional 442,356 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in Amdocs by 5.2% in the second quarter. Massachusetts Financial Services Co. MA now owns 7,099,586 shares of the technology company's stock valued at $591,466,000 after buying an additional 352,436 shares during the last quarter. Institutional investors and hedge funds own 88.11% of the company's stock.

Amdocs Stock Performance


Shares of NASDAQ DOX traded up $0.23 during midday trading on Tuesday, reaching $90.61. 118,125 shares of the company traded hands, compared to its average volume of 601,735. Amdocs Limited has a 52 week low of $72.98 and a 52 week high of $92.80. The stock has a 50-day moving average price of $88.61 and a 200 day moving average price of $85.57. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.60 and a quick ratio of 1.60. The company has a market cap of $10.95 billion, a price-to-earnings ratio of 20.36, a PEG ratio of 1.49 and a beta of 0.66.

Amdocs (NASDAQ:DOX - Get Rating) last released its earnings results on Tuesday, November 8th. The technology company reported $1.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.16 by $0.01. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a return on equity of 16.62% and a net margin of 12.01%. Amdocs's revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.07 earnings per share. Sell-side analysts anticipate that Amdocs Limited will post 5.3 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, December 30th will be paid a dividend of $0.395 per share. The ex-dividend date is Thursday, December 29th. This represents a $1.58 annualized dividend and a yield of 1.74%. Amdocs's dividend payout ratio (DPR) is presently 35.59%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on DOX. Oppenheimer reiterated an "outperform" rating and issued a $84.00 target price on shares of Amdocs in a research note on Thursday, November 10th. Barclays raised their target price on Amdocs to $100.00 in a research note on Tuesday, November 15th. StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, October 11th. Citigroup cut their price objective on shares of Amdocs from $99.00 to $96.00 and set a "buy" rating on the stock in a research note on Wednesday, November 9th. Finally, Robert W. Baird cut their price objective on shares of Amdocs to $85.00 in a research note on Tuesday, November 15th.

About Amdocs

(Get Rating)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers.

Featured Articles

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX - Get Rating).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Amdocs right now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by entering your email address below.

Get This Free Report
20 Stocks to Sell Now Cover

Featured Articles and Offers

Search Headlines: